Skip to content

Intraoperative Warming Comparison of Devices

Intraoperative Warming : Comparison of Performance of the Dynatherm Medical vitalHEAT™ Temperature Management System (vH2) and the Arizant Bair Hugger System

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00650260
Enrollment
42
Registered
2008-04-01
Start date
2009-02-28
Completion date
2009-08-31
Last updated
2012-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypothermia

Keywords

intraoperative warming, anesthesia, hypothermia, body temperature

Brief summary

Hypothermia is a common and serious complication during anesthesia and surgery. Anesthetic-induced hypothermia results from the inhibition of thermoregulatory control and exposure to cold operating room environment. Various warming methods, such as warm blankets, forced-air warmers and circulating water mattresses, are currently used to prevent and treat mild perioperative hypothermia. All are cutaneous approaches that rely on heating the peripheral tissues in order to increase the thermal core temperature. Application of cutaneous warming system blankets/pads are limited by location/extent of operative site; for example, in certain procedures such as laparatomies, reconstructive plastic surgery or orthopedic surgery, only a limited amount of skin surface is available for warming application. The Dynatherm vitalHEAT technology takes advantage of the body's natural thermoregulatory system to channel thermal energy to the body's core non-invasively at a rapid rate. The vital heat (vH2) system is designed to treat hypothermia during the peri-operative period through a combination of localized heat and vacuum application to one hand & forearm; this application 1) opens the arteriovenous anastamoses located in the palm of the hand and 2) conductively warms the extremity thus effectively warming the blood flow to the body's core. The vital heat vH2 system is a portable and compact warming device which provides a non-invasive approach to warming patients during surgery. The primary objective of this study is to determine if the Dynatherm Medical vitalHEAT (vH2) Temperature Management System is as effective as the forced-air warming Bair Hugger™ (Arizant Healthcare, Eden Prairie, MN) for maintenance of intraoperative body temperature in patients undergoing abdominal surgery under general anesthesia. The critical endpoints to be evaluated in making this determination are 1) % of subjects with an average intraoperative esophageal temperature of ≥ 36º C and 2) % of subjects with an initial post anesthesia care unit sublingual temperature of ≥ 36º C. Secondary objectives include 1) comparison of the core body temperatures @ 60 minutes post anesthesia induction, 2) comparison of temperature trends during surgery and 3) comparison of the subjects' post anesthesia care unit temperature trends and hypothermic symptoms such as shivering.

Interventions

DEVICEDynatherm Medical vitalHEAT Temperature Management System vH2

The vH2 system consists of a Control Unit containing the heating system and the vacuum generation pump which connects via an umbilical containing the fluid and vacuum tubing to the Warming Sleeve. The Control Unit also contains the user interface and alarm management systems. The disposable Warming Sleeve consists of a manifold attached to the warming pads and a polyurethane pouch (Vacuum Sleeve) that are placed over the patient's hand and forearm and secured with tape. The Warming Sleeve manifold contains connectors for the fluid and vacuum tubing contained in the umbilical.

DEVICEBair Hugger™ (Arizant Healthcare, Eden Prairie, MN)

The Bair Hugger system is the current standard of care at Tampa General Hospital. It consists of a Temperature Management Unit that contains the heating element, the air circulating motor and the temperature control mechanisms. This unit connects via a hose to the operating room blankets. The Bair Hugger technology relies on heated air convection. Warm air is circulated evenly through the air space in the specially designed blanket, warming the skin surface as well as any insulating blankets placed over the Bair Hugger blanket.

Sponsors

University of South Florida
Lead SponsorOTHER
Dynatherm Medical Inc.
CollaboratorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients undergoing elective open abdominal surgical procedures with an expected duration of 2 to 4 hours and requiring general anesthesia * American Society of Anesthesiologists(ASA) physical status I-III * Patient age: \> 18 years and \<80 years

Exclusion criteria

* Patient age: \< 18 years and \>80 years * Patients with break in skin integrity on the extremity selected as the application site * Patients with history of upper extremity peripheral vascular disease * Patients with history of allergic skin conditions of the upper extremities * Patients with history of bleeding disorders/coagulopathy * Patient with history of malignant hyperthermia * Patients who are pregnant * Patient unwilling or unable to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
Percent of Patients With an Average Intraoperative Temperature Greater Than or Equal to 36 CelciusIntraoperative Period
Percent of Subjects With an Initial PACU Sublingual Temperature of ≥ 36º C.Temp taken just prior to surgery
Percentage of Patients With a Post Operative Sublingual Temperature Above 36 Degrees CelciusUpon entry to the post anesthesia care unitPercent of subjects with an initial post anesthesia care unit sublingual temperature of ≥ 36º C

Secondary

MeasureTime frameDescription
Comparison of the Core Body Temperatures at 60 Minutes Post Anesthesia Induction,as Assessed by Esophageal Probe.60 minutes post anesthesia inductionAverage core body temperature measured with an esophageal probe at 60 minutes post-induction
Average Intraoperative Esophageal TemperatureIntraoperative 0-70 minutesAverage esophageal temperature for the first 70 minutes of surgery following induction of anesthesia.
Median Post Anesthesia Care Unit Sublingual TemperatureUpon arrival to the post anesthesia care unit

Countries

United States

Participant flow

Recruitment details

Subjects were recruited as they arrived for a scheduled surgical procedure at Tampa General Hospital. Potential subjects were addressed in a private pre-operative room. The investigators or study designee evaluated the patients for the study by reviewing the inclusion and exclusion criteria.

Participants by arm

ArmCount
vH2 System Group
The vH2 system consists of a Control Unit containing the heating system and the vacuum generation pump which connects via an umbilical containing the fluid and vacuum tubing to the Warming Sleeve. The Control Unit also contains the user interface and alarm management systems. The disposable Warming Sleeve consists of a manifold attached to the warming pads and a polyurethane pouch (Vacuum Sleeve) that are placed over the patient's hand and forearm and secured with tape. The Warming Sleeve manifold contains connectors for the fluid and vacuum tubing contained in the umbilical. The vH2 System will be used for patient warming during these surgical procedures. Monitoring of core temperature via esophageal probe will be done for the purpose of data collection.
21
Control Group
The Bair Hugger system is the current standard of care at TGH. It consists of a Temperature Management Unit that contains the heating element, the air circulating motor and the temperature control mechanisms. This unit connects via a hose to the operating room blankets. The Bair Hugger technology relies on heated air convection. Warm air is circulated evenly through the air space in the specially designed blanket, warming the skin surface as well as any insulating blankets placed over the Bair Hugger blanket. The Bair Hugger System is the site's current approach to patient warming during these surgical procedures. Monitoring of core temperature via esophageal probe will be done for the purpose of data collection.
21
Total42

Baseline characteristics

CharacteristicControl GroupvH2 System GroupTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
6 Participants4 Participants10 Participants
Age, Categorical
Between 18 and 65 years
15 Participants17 Participants32 Participants
Age Continuous46.5 years
STANDARD_DEVIATION 14
51.1 years
STANDARD_DEVIATION 18.3
48.7 years
STANDARD_DEVIATION 16.5
Region of Enrollment
United States
21 participants21 participants42 participants
Sex: Female, Male
Female
11 Participants10 Participants21 Participants
Sex: Female, Male
Male
10 Participants11 Participants21 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 210 / 21
serious
Total, serious adverse events
0 / 210 / 21

Outcome results

Primary

Percentage of Patients With a Post Operative Sublingual Temperature Above 36 Degrees Celcius

Percent of subjects with an initial post anesthesia care unit sublingual temperature of ≥ 36º C

Time frame: Upon entry to the post anesthesia care unit

ArmMeasureValue (NUMBER)
vH2 System GroupPercentage of Patients With a Post Operative Sublingual Temperature Above 36 Degrees Celcius95 Percentage of participants
Control GroupPercentage of Patients With a Post Operative Sublingual Temperature Above 36 Degrees Celcius100 Percentage of participants
Primary

Percent of Patients With an Average Intraoperative Temperature Greater Than or Equal to 36 Celcius

Time frame: Intraoperative Period

ArmMeasureValue (NUMBER)
vH2 System GroupPercent of Patients With an Average Intraoperative Temperature Greater Than or Equal to 36 Celcius56 percentage of participants
Control GroupPercent of Patients With an Average Intraoperative Temperature Greater Than or Equal to 36 Celcius90 percentage of participants
p-value: 0.027Fisher Exact
Primary

Percent of Subjects With an Initial PACU Sublingual Temperature of ≥ 36º C.

Time frame: Temp taken just prior to surgery

Population: Per protocol, sample size calculations indicate that a total sample size of 42 patients will be necessary to evaluate the primary outcome at an adjusted alpha = 0.05 with 80% power.

ArmMeasureValue (NUMBER)
vH2 System GroupPercent of Subjects With an Initial PACU Sublingual Temperature of ≥ 36º C.95 Percentage of participants
Control GroupPercent of Subjects With an Initial PACU Sublingual Temperature of ≥ 36º C.100 Percentage of participants
p-value: 1Fisher Exact
Secondary

Average Intraoperative Esophageal Temperature

Average esophageal temperature for the first 70 minutes of surgery following induction of anesthesia.

Time frame: Intraoperative 0-70 minutes

ArmMeasureValue (MEAN)
vH2 System GroupAverage Intraoperative Esophageal Temperature36.3 Degrees Celcius
Control GroupAverage Intraoperative Esophageal Temperature36.0 Degrees Celcius
Secondary

Comparison of the Core Body Temperatures at 60 Minutes Post Anesthesia Induction,as Assessed by Esophageal Probe.

Average core body temperature measured with an esophageal probe at 60 minutes post-induction

Time frame: 60 minutes post anesthesia induction

ArmMeasureValue (MEAN)Dispersion
vH2 System GroupComparison of the Core Body Temperatures at 60 Minutes Post Anesthesia Induction,as Assessed by Esophageal Probe.36.4 degrees celciusStandard Deviation 0.4
Control GroupComparison of the Core Body Temperatures at 60 Minutes Post Anesthesia Induction,as Assessed by Esophageal Probe.36.1 degrees celciusStandard Deviation 0.5
p-value: 0.078t-test, 1 sided
Secondary

Median Post Anesthesia Care Unit Sublingual Temperature

Time frame: Upon arrival to the post anesthesia care unit

ArmMeasureValue (MEDIAN)
vH2 System GroupMedian Post Anesthesia Care Unit Sublingual Temperature36.4 Degrees Celcius
Control GroupMedian Post Anesthesia Care Unit Sublingual Temperature36.6 Degrees Celcius

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026